WebCymbalta® (duloxetine hydrochloride) is a selective serotonin and norepinephrine reuptake inhibitor (SSNRI) for oral administration. Its chemical designation is (+)-(S)-N-methyl-γ-(1-naphthyloxy)-2-thiophenepropylamine hydrochloride. The empirical formula is C18H19NOS•HCl, which corresponds to a molecular weight of 333.88. The structural ... WebMay 24, 2024 · Cymbalta (duloxetine hydrochloride) is a serotonin-norepinephrine reuptake inhibitor (SNRI) antidepressant. It is taken by mouth as a pill or capsule. Cymbalta may help improve a number of symptoms of depression including mood, appetite, sleep, and energy levels. As an SNRI, duloxetine inhibits the reuptake of the neurotransmitters …
Cymbalta: Dosing, contraindications, side effects, and pill ... - Epocrates
WebFeb 1, 2024 · Cymbalta; Drizalma Sprinkle; Irenka; ... For non-prescription products, read the label or package ingredients carefully. Pediatric . Appropriate studies performed to date have not demonstrated pediatric-specific problems that would limit the usefulness of duloxetine in children to treat anxiety in children 7 years of age and older. However ... WebAug 21, 2024 · The active ingredient in Cymbalta is duloxetine. An active ingredient is what makes a drug work. It belongs to a group of drugs called serotonin-norepinephrine … ipmc tema
Which Medications Contain Animal Byproducts, and Why? - GoodRx
WebSuicidality. incr. suicidality risk in children, adolescents, and young adults w/ major depressive or other psychiatric disorders; weigh risk vs. benefit; in short-term studies of antidepressants vs. placebo, suicidality risk not incr. in pts >24 yo, and risk decr. in pts 65 yo and older; depression and certain other psychiatric disorders themselves assoc. w/ incr. … Cymbalta® (duloxetine delayed-release capsules) is a selective serotonin and norepinephrine reuptake inhibitor (SNRI) for oral administration. Its chemical designation is (+)-(S)-N-methyl-γ-(1-naphthyloxy)-2-thiophenepropylamine hydrochloride. The empirical formula is C18H19NOS•HCl, which … See more Cymbalta®is indicated for the treatment of: 1. Major depressive disorder in adults 2. Generalized anxiety disorder in adults and pediatric patients 7 years of age and older 3. Diabetic peripheral neuropathic pain in adults 4. … See more The use of MAOIs intended to treat psychiatric disorders with Cymbalta or within 5 days of stopping treatment with Cymbalta is … See more Cymbalta is available as delayed-release capsules: 1. 20 mg opaque green capsules imprinted with “Lilly 3235 20mg” 2. 30 mg opaque white and blue capsules imprinted with “Lilly 3240 30mg” 3. 60 mg opaque green and … See more orba artiphon presets